Cost-effectiveness and cost-utility analysis of Belimumab for the treatment of patients with systemic Lupus Erythematosus in Portugal

Research output: Contribution to journal › Meeting Abstract › peer-review

Access to Document

@article{0a29791335cc48b18196e21548d50c46,

title = "Cost-effectiveness and cost-utility analysis of Belimumab for the treatment of patients with systemic Lupus Erythematosus in Portugal",

author = "M. Gouveia and M. Borges and M. Augusto and J. Costa and M. Treur and S. Lopes",

year = "2013",

month = nov,

day = "1",

doi = "10.1016/j.jval.2013.08.354",

language = "English",

volume = "16",

pages = "A384--A384",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Cost-effectiveness and cost-utility analysis of Belimumab for the treatment of patients with systemic Lupus Erythematosus in Portugal

AU - Gouveia, M.

AU - Borges, M.

AU - Augusto, M.

AU - Costa, J.

AU - Treur, M.

AU - Lopes, S.

PY - 2013/11/1

Y1 - 2013/11/1

U2 - 10.1016/j.jval.2013.08.354

DO - 10.1016/j.jval.2013.08.354

M3 - Meeting Abstract

SN - 1098-3015

VL - 16

SP - A384-A384

JO - Value in Health

JF - Value in Health

IS - 7

ER -